The european platelet rich plasma (PRP) market is poised for significant expansion, with forecasts projecting it will exceed USD 80.3 million by 2033. Recent insights reveal that the PRP therapy sector in Europe, valued at USD 57.5 million in 2023, is expected to achieve a Compound Annual Growth Rate (CAGR) of 3.4% over the next …